极光加速器2025官网
We are currently recruiting for the Phase 3 study of MDMA-assisted psychotherapy for PTSD. Here is a list of all MAPS-sponsored trials on clinicaltrials.gov.
MAPS PBC is a wholly-owned subsidiary of the Multidisciplinary Association for Psychedelic Studies (MAPS). MAPS is a 501(c)(3) non-profit research and educational organization that develops medical, legal, and cultural contexts for people to benefit from the careful uses of psychedelics and marijuana.
极光加速器2025官网
极光加速器2025官网
June 10, 2025 极光加速器2025官网
June 3, 2025 极光加速器2025官网
May 16, 2025 极光加速器2025官网
May 10, 2025 极光加速器2025官网
The Lancet: Psychiatry
MDMA-assisted psychotherapy for PTSD in military veterans, firefighters, and police officers: a randomised, double-blind, dose-response, phase 2 clinical trial.
Psychopharmacology: Pooled CAPS Study
Here we evaluate six phase 2 trials in a pooled analysis to determine the study design for phase 3 trials of MDMA-assisted psychotherapy for PTSD. MDMA-assisted psychotherapy was efficacious and well tolerated in a large sample of adults with PTSD.
什么加速器可伡看油管
Learn more about all of our completed, ongoing and planned studies, and see all of our publications on our Study Information page.